NL-OMON25892招募中不适用
Fecal therapy to Eliminate Clostridium difficile Associated Longstanding diarrhoea.
Academic Medical Center Amsterdamthe Netherlands0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patient 18 years or older;
- •2. proven recurrence of Clostridium difficile associated diarrhoea (positive toxin test and diarrhoea defined as more than 3 loose or watery stools per day or >8 in 48 hours);
排除标准
- •1. Pregnancy;
- •2. life expectancy of less than three months;
研究者
相似试验
尚未招募
3 期
Treatment of recurrent Clostridium difficile infection with fecal therapy: the FECAL trial (Fecal enema to Eliminate Clostridium difficile Associated Longstanding diarrhea)bacterial infectionschronic diarrhea1001796610004018NL-OMON30253Academisch Medisch Centrum136
Unknown
1 期
Reduction of C-Difficile Infection Using Stool TransplantC-difficileNCT02112279Providence Holy Cross Medical Center10
已完成
不适用
Effectiveness of Isolating Clostridium Difficile Asymptomatic Carriers on the Incidence of InfectionsClostridium DifficileNCT03223415Yves Longtin4,138
已完成
不适用
Fecal microbiota transplantation for Clostridium difficile infectioPseudomembranous colitis, Clostridium difficile infectionJPRN-UMIN000016900Shiga University of Medical Science10
已完成
不适用
Clostridium difficile - adjuvant therapy with high dose VSL#3® will shorten hospital stay and reduce relapse rates in Clostridium difficile associated diarrhoeaISRCTN57305201niversity Hospitals Bristol NHS Foundation Trust (UK)114